Introduction {#sec1}
============

Ubiquitination of specific cellular proteins serves as a signal for protein degradation, chromatin remodeling, DNA repair, vesicular transport, and changes in protein localization and/or activity depending on the number and structure of the ubiquitin modification.^[@ref2],[@ref3]^ Protein ubiquitination is highly regulated and requires a cascade of enzymes that culminates in a substrate and site-specific modification. Similarly, deubiquitinating enzymes (DUBs) that remove ubiquitin (or ubiquitin-like modifiers like SUMO or Nedd8) from substrate proteins to allow recycling of ubiquitin and/or modulation of signaling pathways must be tightly controlled.

Ubiquitination and kinase cascades intersect on multiple levels and together they orchestrate key cellular events including endocytosis, cell cycle progression, and growth factor signaling.^[@ref4]−[@ref9]^ Kinases activate E3 ubiquitin ligases (e.g., the anaphase promoting complex/cyclosome) which in turn ubiquitinate kinases (e.g., Polo) or kinase regulatory subunits (e.g., the cyclin subunit of cyclin-dependent kinases (CDK)).^[@ref10]−[@ref13]^ Kinases also regulate protein turnover by marking substrates for phosphorylation-dependent ubiquitin-mediated degradation (e.g., by the SCF ubiquitin ligase).([@ref14]) There are many other examples of cross-regulation of ubiquitin and kinase signaling networks, including phosphorylation of deubiquitinating enzymes (e.g., CYLD).([@ref15]) Here we set the stage for understanding how DUBs might be regulated by kinases and phosphatases by cataloging phosphorylation sites of all *S. pombe* DUBs.

DUBs are a highly conserved family of proteases involved in: (1) processing of ubiquitin precursor proteins, (2) recovery of modified ubiquitin trapped in inactivatable forms, (3) cleavage of ubiquitin from target proteins, and (4) recycling of monoubiquitin from free polyubiquitin chains.^[@ref16]−[@ref18]^ The diversity of DUB functions is reflected in the number of DUBs (95 predicted human DUBs), the variety of catalytic domains---ubiquitin C-terminal hydrolases (UCH), ubiquitin-specific proteases (USP), ovarian tumor proteases (OTU), Machado-Joseph disease proteases (MJD) and JAB1/MPN/Mov34 metalloenzymes (JAMM)([@ref16]) and DUB domain architecture.([@ref1])

*S. pombe* is an amenable organism in which to conduct a global study of DUB function and regulation because of the limited number of DUBs containing the required catalytic residues (20), the diversity and conservation of catalytic domains (4 of 5 classes, see Table [1](#tbl1){ref-type="table"}), and the genetic tractability of yeast. We recently reported the cellular localization, enzymatic activity profiles and protein interaction networks of the entire *S. pombe* DUB family.([@ref1]) A few phosphorylation sites for some *S. pombe* DUBs have been reported in large-scale phosphoproteomics studies,^[@ref19],[@ref20]^ but a detailed analysis of DUB phosphorylation is lacking. To begin to understand how phosphorylation impacts DUB regulation, we examined the phosphostatus of the entire *S. pombe* DUB family and their binding partners using tandem affinity purification (TAP) followed by multidimensional LC-MS/MS (MudPIT) from asynchronous and mitotic cell cultures (Figure [1](#fig1){ref-type="fig"}). Here, we present the global phosphorylation status of the *S. pombe* DUBs and their partners and discuss the implications of these modifications on DUB regulation in eukaryotes.

![Experimental scheme for DUB purifications, LC−MS/MS analysis, and phosphopeptide identification and verification.](pr-2010-00985s_0008){#fig1}

###### *S. pombe* Deubiquitinating Enzymes (DUBs)

  --
  --

Experimental Methods {#sec2}
====================

Yeast Strains, Media, Genetic Methods, and Vector Construction {#sec2.1}
--------------------------------------------------------------

Strain construction and tetrad analysis were accomplished through standard methods. Endogenously tagged strains (Supplemental Table 1, [Supporting Information](#notes-1)) were grown in yeast extract (YE) media. For expression of N-terminally tagged proteins, strains were transformed with pREP expression vectors, containing a thiamine repressible promoter, using a standard sorbitol transformation procedure.([@ref21]) Transformed strains were first grown on minimal media containing thiamine to suppress expression and then, to induce expression, cells were grown in minimal media lacking thiamine for 18 h.([@ref22]) Cell cultures used for TAP purifications were grown in 2 L of 4× YE media (C-terminally TAP tagged proteins) or in 8 L of minimal media supplemented with the appropriate nutrients (N-terminally TAP tagged proteins). All 20 DUBs were tagged endogenously at the 3′ end with TAP or linker-TAP as previously described.([@ref23]) The linker sequence in the linker-TAP cassettes translates to ILGAPSGGGATAGAGGAGGPAGLI.([@ref24]) N-TAP cassettes for Ubp1, Ubp7, and Ubp11 were constructed as previously described.([@ref1])

For mitotic purifications of the nuclear DUBs (Ubp6, Ubp8, Ubp9, Ubp12, Ubp14, Ubp15, Ubp16, Uch1, Uch2, Otu1, and Rpn11), log phase cells containing DUB TAP tags were blocked using a cold sensitive allele of β-tubulin (*nda3-KM11*, prometaphase) and/or released for 30 min (anaphase). Cells were snap frozen in a dry ice ethanol bath and subjected to TAP/LC-MS/MS as described below.

Protein Methods {#sec2.2}
---------------

Cell pellets were frozen in a dry ice/ethanol bath and lysed by bead disruption in NP-40 lysis buffer under native (Figure [2](#fig2){ref-type="fig"}c) or denaturing conditions (Figure [2](#fig2){ref-type="fig"}a/b) as previously described,([@ref25]) except with the addition of 0.1 mM diisopropyl fluorophosphate (Sigma-Aldrich). Proteins were immunoprecipitated by IgG Sepharose beads (GE Healthcare) or anti-GFP (Roche). For phosphatase collapse, immunoprecipitated proteins were incubated with lambda phosphatase (New England Biolabs) in 25 mM HEPES-NaOH pH 7.4, 150 mM NaCl, and 1 mM MnCl~2~ for 30 min at 30 °C. Immunoblot analysis was performed as previously described([@ref26]) except that secondary antibodies were conjugated to Alexa Fluor 680 (Invitrogen) and visualized using an Odyssey Infrared Imaging System (LI-COR Biosciences).

For the block and release experiment, a temperature sensitive strain (*cdc25−22* Ubp9-TAP) was grown overnight at 25 °C and then shifted to the nonpermissive temperature (36 °C) for 3 h to block cells in G2. The cells were then released to the permissive temperature and 20 OD pellets were collected every 15 min. Lysates and immunoprecipitations were performed as described above except IgG coated dynabeads (Invitrogen) were used for immunoprecipitation.

DUB purification and LC−MS/MS analysis {#sec2.3}
--------------------------------------

Proteins were purified by TAP as described,([@ref27]) or using a one step dynabead purification as follows: tosylactivated M-280 Dynabeads were coupled to rabbit IgG (Invitrogen) and used to pull down TAP tagged proteins from native lysates (as in TAP protocol) and then the proteins were eluted using high pH. The purified proteins were then TCA precipitated and digested with trypsin (Promega), chymotrypsin (Princeton Separations), and/or GluC (Thermo) and the resulting peptides were subjected to mass spectrometric analysis on a Thermo LTQ as previously detailed.^[@ref28],[@ref29]^ Thermo RAW files were converted to MZML files using Scansifter (software developed in-house at the Vanderbilt University Medical Center). Spectra with less than 20 peaks were excluded from our analysis. The *S. pombe* database (<http://www.sanger.ac.uk>, October 2009) was searched with the Myrimatch algorithm([@ref30]) v1.6.33 on a high performance computing cluster (Advanced Computing Center for Research & Education at Vanderbilt University). We added contaminant proteins (e.g., keratin, IgG) to the complete *S. pombe* database and reversed and concatenated all sequences to allow estimation of false discovery rates (10 186 entries). Myrimatch parameters were as follows: strict tryptic cleavage; modification of methionine (oxidation, dynamic modification, +16 Da), S/T/Y (phosphorylation, dynamic modification, +80 Da) and cysteine (carboxamidomethylation, static modification, +57 Da) was allowed; precursor ions were required to be within 0.6 *m*/*z* of the peptide monoisotopic mass; fragment ions were required to fall within 0.5 *m*/*z* of the expected monoisotopic mass. IDPicker^[@ref31],[@ref32]^ v2.6.126.0 was used to filter peptide matches with the following parameters: max. FDR per result 0.01, max. ambiguous IDs per result 2, min peptide length per result 5, min distinct peptides per protein 3, min additional peptides per protein group 2, minimum number of spectra per protein 3, indistinct modifications M 15.994 Da, C 57.05 Da and distinct modifications S/T/Y 80 Da. IDPicker results were processed in Excel (Microsoft) to generate phosphopeptide lists for the DUBs and their binding partners. Spectra were manually inspected and annotated in SeeMS and a related program called PTMDigger, software developed by in-house (Surendra Dasari, Matthew Chambers, and David Tabb, Vanderbilt University Medical Center). Supplemental Figure 1 ([Supporting Information](#notes-1)) was generated using software developed in-house (Zeqiang Ma, Surendra Dasari, Matthew Chambers, and David Tabb, Vanderbilt University Medical Center). DUBs and partners were purified with sequence coverage (%) as follows: Otu1 − 51, Otu2 − 35, Ubp1 − 67, Ubp2 − 95, Ubp3 − 64, Ubp4 − 42, Ubp5 − 72, Ubp6 − 56, Ubp7 − 81, Ubp8 − 62, Ubp9 − 67, Ubp11 − 71, Ubp12 − 67, Ubp14 − 80, Ubp15 − 88, Ubp16 − 44, Rpn11 − 63, Sst2 − 65, Uch1 − 84, Uch2 − 82, Ucp6 − 78, Nxt3 − 71, Sfp47 − 46, Ftp105 − 58, Bun62 − 57 and Bun107 − 64. Note that mildly overexpressed N-terminal TAP fusions were used for the low abundance DUBs Ubp1, Ubp7 and Ubp11. For complete protein identification information for each TAP, see a previous publication.([@ref1]) Using the stringent filter of FDR \< 1%, approximately 1500 mass spectra contained +80 Da shifts, indicative of phosphorylation. These spectra were manually inspected and filtered according to the following criteria: (1) exhibit a prominent (often base) 98 Da (H~3~PO~4~) neutral loss peak at the MS2 level and (2) b and y ion intensities \>20% of the neutral loss peak (3) contained two or more sequential fragments (b and/or y) bracketing the phosphorylation site(s); 1242 spectra met these criteria. Phosphorylation sites were assigned based on the presence of sequential fragment ions surrounding the modification; if these ions were missing, the phosphorylation site(s) were assigned to multiple sites ambiguously.

Results and Discussion {#sec3}
======================

Deubiquitinating enzymes are present in nearly every cellular compartment([@ref1]) (Table [1](#tbl1){ref-type="table"}) and participate in essential cellular processes including regulation of endocytosis, protein degradation, transcription, DNA repair, and protein localization and/or activity.([@ref18]) We and others have shown that DUBs are regulated by interaction with protein partners^[@ref1],[@ref18],[@ref33]^ and now we have assessed the phosphostatus of the *S. pombe* DUB family to set the stage for understanding the interplay of phosphorylation and ubiquitination.

Each of the 20 *S. pombe* DUBs was purified two or more times from asynchronous cultures using an endogenous C-terminal TAP tag or an inducible N-terminal TAP tag (see [Experimental Methods](#sec2) for details).([@ref1]) We also performed purifications of the (partially) nuclear DUBs (Ubp6, Ubp8, Ubp9, Ubp12, Ubp14, Ubp15, Ubp16, Uch1, Uch2, Rpn11, and Otu1) from cells arrested in prometaphase using the tubulin mutation, *nda3-KM11,* and released for 30 min into anaphase to enrich our data set with mitotic phosphorylation events (denoted in Tables [2](#tbl2){ref-type="table"}, [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}). Each purification was precipitated, digested, and analyzed on a Thermo LTQ using a MudPIT protocol (see [Experimental Methods](#sec2) for details). The resultant mass spectra were processed using software developed at Vanderbilt Medical Center (Figure [1](#fig1){ref-type="fig"}) to identify phosphorylation sites.

###### Phosphorylation Sites Detected for Cytoplasmic *S. pombe* DUBs

  --
  --

###### Phosphorylation Sites Detected for (Partially) Nuclear *S. pombe* DUBs

  --
  --

###### Phosphorylation Sites Detected for Partners of *S. pombe* DUBs

  --
  --

Over 1500 mass spectra (FDR \> 0.5%) indicative of phosphorylation (+80 Da) were identified from our bioinformatic analysis (Figure [1](#fig1){ref-type="fig"}) and manual validation showed 1242 spectra corresponding to phosphorylation sites (for criteria see [Experimental Methods](#sec2)). The overall spectral quality and peptide sequence coverage is illustrated with two examples of parent and daughter spectra (Supplemental Figures 2 and 3, [Supporting Information](#notes-1)). In total, we identified over 130 phosphorylation sites in over half (12/20) of the *S. pombe* DUBs and DUB partners (Tables [2](#tbl2){ref-type="table"}, [3](#tbl3){ref-type="table"}, and [4](#tbl4){ref-type="table"}). Only ca. 15% of the phosphosites we identified have been previously reported (see Supplemental Table 2 for details, [Supporting Information](#notes-1)).^[@ref19],[@ref20]^ We confirmed biochemically that Upb9, Bun107, Ftp105 and Sfp47 are phosphoproteins by lambda phosphatase collapse and Western blot (Figure [2](#fig2){ref-type="fig"}a). The other DUBs exhibited no discernible gel shift after phosphatase treatment (data not shown), but gel conditions were not optimized for each protein.

![Biochemical analysis of DUB phosphorylation a) Lambda phosphatase collapse for Ubp9, Bun107, Sfp47, and Ftp105 b) phosphorylation status of Ubp9 in the presence or absence of its WD partners and c) block and release experiment illustrating the cell cycle dependency of Ubp9 phosphorylation (see Experimenal Methods for details).](pr-2010-00985s_0009){#fig2}

Cell Cycle Regulation of DUB Phosphorylation {#sec3.1}
--------------------------------------------

The mitotic purifications revealed upregulated \[st\]P proline-directed kinase consensus sites, as one might expect for modification by mitotic CDK. Phosphorylation sites detected in Ubp6, Ubp9 and its partner Bun107 were much more abundant in the mitotic purifications (denoted in Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}), suggesting that these DUBs are cell cycle regulated. Ubp6 is recruited to the proteasome under conditions of ubiquitin stress([@ref34]) which was not the case for our experiments, but it is possible that mitotic phosphorylation plays some role in localization or activity of Ubp6.

Phosphorylation of Ubp9 is clearly cell cycle dependent based on block and release experiments (Figure [2](#fig2){ref-type="fig"}c) and enrichment of S11 phosphopeptides identified from mitotic cells; thus, phosphorylation may alter the affinity of Ubp9 for its substrates and/or enhance its catalytic activity rather than affect its cellular localization (which is regulated by its WD partners, see discussion below). All components of the Ubp9 complex are phosphorylated (this study) and conserved throughout eukaryotes.([@ref35]) The larger WD partner, Bun107, contains multiple phosphorylation sites consistent with CDK phosphorylation based on amino acid sequence and increased abundance in mitotic purifications (Table [4](#tbl4){ref-type="table"}).

Phosphorylation of DUB Complexes {#sec3.2}
--------------------------------

Cross-regulation between ubiquitination and phosphorylation appears to be a common theme for DUB complexes. Over half of the DUBs interact with protein partners near stoichiometric ratios([@ref1]) and most of these DUBs *and* their partners are phosphorylated (Tables [1](#tbl1){ref-type="table"}−[4](#tbl4){ref-type="table"} and Figure [3](#fig3){ref-type="fig"}), signifying that kinases and phosphosphatases regulate DUBs. Ubp9, a DUB present in the nucleus and at cell tips and septa, is part of a complex containing two WD proteins (Bun62 and Bun107). Both WD partners are required for Ubp9′s DUB activity and regulate its cellular localization.([@ref1]) The Ubp9 complex shuttles between the nucleus and cytoplasm, but at steady state, accumulates at active sites of endocytosis (cell tips and septa). When Bun62 is deleted, Ubp9 localizes to cell tips and septa, but not the nucleus, whereas deletion of Bun107 causes retention of Ubp9 in the nucleus.([@ref1]) We have discovered that Ubp9 and both of its partners are phosphorylated (Tables [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"} and Figures [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). To investigate how phosphorylation might impact Ubp9 localization or function, we examined the phosphostatus of Ubp9 in strains where each partner had been deleted individually and in combination (Figure [2](#fig2){ref-type="fig"}b). When either WD partner is lost, Ubp9 is no longer efficiently phosphorylated (Figure [2](#fig2){ref-type="fig"}b), suggesting that Ubp9 is not competent for phosphorylation unless it is in complex with its partners. Both partners of four other DUB complexes are phosphorylated, including two cytoplasmic DUBs Ubp2 and Ubp3 and their partners Ucp6 and Nxt3, respectively, and two endocytic DUBs Ubp4 and Ubp5 and their partners Sfp47 and Ftp105, respectively (Tables [2](#tbl2){ref-type="table"} and [4](#tbl4){ref-type="table"}, Figures [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). Sfp47, an SH3 domain protein, and Ftp105, a putative transmembrane protein, recruit their respective DUB partners to specific cellular locations (endosomes for Ubp4 and the Golgi for Ubp5).([@ref1]) Phosphorylation and dephosphorylation cycles may modulate complex formation, cellular localization, DUB activity and/or substrate specificity.

![Domain architecture and mapping of detected phosphorylation sites within the *S. pombe* DUBs and their partners. Domain architectures were retrieved using the SMART and Pfam databases. The following domains were found: USP (ubiquitin-specific proteases) JAMM (JAB1/MPN/Mov34 metalloenzymes), DUSP (Domain in Ubiquitin-specific proteases), MATH (Meprin and TRAF homology), UBL (Ubiquitin-like), ZnF (Ubiquitin Carboxyl-terminal hydrolase-like zinc finger), UBA (Ubiquitin-associated). RPT are internal repeats. Phosphosites are denoted by vertical black lines.](pr-2010-00985s_0010){#fig3}

Location of Phosphosites within DUBs and Their Partners {#sec3.3}
-------------------------------------------------------

Surprisingly, most of the DUB phosphorylation sites map to the catalytic DUB domains (Figure [3](#fig3){ref-type="fig"}). In fact, all detected sites for Ubp7 are within its extended USP domain, suggesting that its catalytic activity and/or structure could be regulated by phosphorylation. Ubp2 and Ubp12 each have two clusters of phosphosites---one within their USP domain and one near the N-terminus; perhaps this arrangement allows tuning of DUB cellular localization, substrate binding or catalytic activity by kinases and phosphatases. Finally, two endocytic DUBs Ubp5 and Ubp9 have two clusters of sites at their N- and C- termini, respectively, predominately outside the USP domains. As discussed above, the cellular localization of these two DUBs is regulated by protein partners([@ref1]) and so phosphorylation may add another layer of regulation for substrate binding and/or catalytic activity. The phosphosites detected for the DUB partners also cluster within or very near domains (e.g., Ubcp6 and Ftp105) or in regions predicted to be intrinsically disordered (e.g., Sfp47 and Bun107) (Figure [3](#fig3){ref-type="fig"}). These sites may regulate the availability of specific protein domains for interaction with other partners or the catalytic activity of the holo DUB complex.

DUB Phosphorylation Consensus Motifs {#sec3.4}
------------------------------------

Given the diversity of DUB cellular localization and function, it is not surprising that the DUB phosphosites match consensus sequences for multiple protein kinases. The majority of DUB phosphopeptides are products of proline-directed kinases (e.g., MAP kinases or CDK) and many others match consensus sites for casein-type kinases (CKI, CKII, see Tables [1](#tbl1){ref-type="table"}−[4](#tbl4){ref-type="table"} and Supplemental Table 2, [Supporting Information](#notes-1)). Phosphosites detected in the exclusively cytoplasmic DUBs also include sequences consistent with PIKK and GSK3 consensus sites and the cellular localization of these kinases (Table [2](#tbl2){ref-type="table"}). While the nuclear DUB sites are primarily proline-directed sites, the partially nuclear DUBs, Ubp9 and Ubp12, have phosphopeptides consistent with phosphorylation by PKA/PKC (Table [3](#tbl3){ref-type="table"}, Supplemental Table 2, [Supporting Information](#notes-1)).

There are also many phosphorylation-dependent WW class IV ligand motifs present in both the cytoplasmic and nuclear DUBs (Tables [2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}), suggesting that DUB interactions with WW domain-containing proteins could be controlled by phosphorylation. For instance, the HECT-type E3 Ub-ligases, Pub1, Pub2 and Pub3 and multiple components of the spliceosome contain WW domains and are likely regulated by a combination of kinases and DUBs. The cytoplasmic DUB Ubp2 and endocytic DUBs Ubp5 and Ubp9 are phosphorylated on sites that match the FHA domain consensus binding motif that may function in localization and/or substrate recognition.

Concluding Remarks {#sec3.5}
------------------

Our results show that the majority of DUBs and most DUB partners are phosphorylated, some in a cell cycle-dependent manner. The phosphosites identified for *S. pombe* DUBs and their partners provide a foundation for understanding the interplay of ubiquitination and phosphorylation in this enzyme class in higher eukaryotes because sites identified in conserved proteins may be conserved or mimicked in higher eukaryotes. Future studies aimed at understanding the intersection of ubiquitination and phosphorylation will be useful for understanding DUB regulation and, more broadly, the cross-regulation of kinase and ubiquitin signaling networks.
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